Gast ::
| Hauptseite > Publikationsdatenbank > Normative database of the serotonergic system in healthy subjects using multi-tracer PET > print |
| Hauptseite > Publikationsdatenbank > Normative database of the serotonergic system in healthy subjects using multi-tracer PET > print |
| 001 | 22784 | ||
| 005 | 20210129210832.0 | ||
| 024 | 7 | _ | |2 pmid |a pmid:22789740 |
| 024 | 7 | _ | |2 DOI |a 10.1016/j.neuroimage.2012.07.001 |
| 024 | 7 | _ | |2 WOS |a WOS:000308770300046 |
| 024 | 7 | _ | |a altmetric:862460 |2 altmetric |
| 037 | _ | _ | |a PreJuSER-22784 |
| 041 | _ | _ | |a eng |
| 082 | _ | _ | |a 610 |
| 084 | _ | _ | |2 WoS |a Neurosciences |
| 084 | _ | _ | |2 WoS |a Neuroimaging |
| 084 | _ | _ | |2 WoS |a Radiology, Nuclear Medicine & Medical Imaging |
| 100 | 1 | _ | |0 P:(DE-HGF)0 |a Savil, M. |b 0 |
| 245 | _ | _ | |a Normative database of the serotonergic system in healthy subjects using multi-tracer PET |
| 260 | _ | _ | |a Orlando, Fla. |b Academic Press |c 2012 |
| 300 | _ | _ | |a 447 - 459 |
| 336 | 7 | _ | |a Journal Article |0 PUB:(DE-HGF)16 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a article |2 DRIVER |
| 440 | _ | 0 | |0 4545 |a NeuroImage |v 63 |x 1053-8119 |y 1 |
| 500 | _ | _ | |a A. Hahn is recipient of a DOC-fellowship of the Austrian Academy of Sciences at the Department of Psychiatry and Psychotherapy, MUV. The other authors declare no conflict of interest.This research was partly supported by grants from the Austrian National Bank (OeNB13214 to R.L. and OeNB13675 M.M.), the Austrian Science Fund and by an unrestricted investigator-initiated research grant from H. Lundbeck A/S to S.K.A. Hahn is recipient of a DOC-fellowship of the Austrian Academy of Sciences at the Department of Psychiatry and Psychotherapy, MUV. |
| 520 | _ | _ | |a The highly diverse serotonergic system with at least 16 different receptor subtypes is implicated in the pathophysiology of most neuropsychiatric disorders including affective and anxiety disorders, obsessive compulsive disorder, post-traumatic stress disorder, eating disorders, sleep disturbance, attention deficit/hyperactivity disorder, drug addiction, suicidal behavior, schizophrenia, Alzheimer, etc. Alterations of the interplay between various pre- and postsynaptic receptor subtypes might be involved in the pathogenesis of these disorders. However, there is a lack of comprehensive in vivo values using standardized procedures. In the current PET study we quantified 3 receptor subtypes, including the major inhibitory (5-HT(1A) and 5-HT(1B)) and excitatory (5-HT(2A)) receptors, and the transporter (5-HTT) in the brain of healthy human subjects to provide a database of standard values. PET scans were performed on 95 healthy subjects (age=28.0 ± 6.9 years; 59% males) using the selective radioligands [carbonyl-(11)C]WAY-100635, [(11)C]P943, [(18)F]altanserin and [(11)C]DASB, respectively. A standard template in MNI stereotactic space served for region of interest delineation. This template follows two anatomical parcellation schemes: 1) Brodmann areas including 41 regions and 2) AAL (automated anatomical labeling) including 52 regions. Standard values (mean, SD, and range) for each receptor and region are presented. Mean cortical and subcortical binding potential (BP) values were in good agreement with previously published human in vivo and post-mortem data. By means of linear equations, PET binding potentials were translated to post-mortem binding (provided in pmol/g), yielding 5.89 pmol/g (5-HT(1A)), 23.5 pmol/g (5-HT(1B)), 31.44 pmol/g (5-HT(2A)), and 11.33 pmol/g (5-HTT) being equivalent to the BP of 1, respectively. Furthermore, we computed individual voxel-wise maps with BP values and generated average tracer-specific whole-brain binding maps. This knowledge might improve our interpretation of the alterations taking place in the serotonergic system during neuropsychiatric disorders. |
| 536 | _ | _ | |0 G:(DE-Juel1)FUEK409 |2 G:(DE-HGF) |x 0 |c FUEK409 |a Funktion und Dysfunktion des Nervensystems (FUEK409) |
| 536 | _ | _ | |0 G:(DE-HGF)POF2-89571 |a 89571 - Connectivity and Activity (POF2-89571) |c POF2-89571 |f POF II T |x 1 |
| 588 | _ | _ | |a Dataset connected to Web of Science, Pubmed |
| 650 | _ | 7 | |2 WoSType |a J |
| 653 | 2 | 0 | |2 Author |a PET |
| 653 | 2 | 0 | |2 Author |a Serotonin |
| 653 | 2 | 0 | |2 Author |a Database |
| 653 | 2 | 0 | |2 Author |a 5-HT1A |
| 653 | 2 | 0 | |2 Author |a 5-HT2A |
| 653 | 2 | 0 | |2 Author |a 5-HT1B |
| 653 | 2 | 0 | |2 Author |a 5-HTT |
| 700 | 1 | _ | |0 P:(DE-Juel1)131672 |a Bauer, A. |b 1 |u FZJ |
| 700 | 1 | _ | |0 P:(DE-HGF)0 |a Mitterhauser, M. |b 2 |
| 700 | 1 | _ | |0 P:(DE-HGF)0 |a Ding, Y.S. |b 3 |
| 700 | 1 | _ | |0 P:(DE-HGF)0 |a Hahn, A. |b 4 |
| 700 | 1 | _ | |0 P:(DE-Juel1)VDB3646 |a Kroll, T. |b 5 |u FZJ |
| 700 | 1 | _ | |0 P:(DE-HGF)0 |a Neumeister, A. |b 6 |
| 700 | 1 | _ | |0 P:(DE-HGF)0 |a Hauesler, D. |b 7 |
| 700 | 1 | _ | |0 P:(DE-Juel1)VDB73156 |a et, al |b 8 |u FZJ |
| 773 | _ | _ | |0 PERI:(DE-600)1471418-8 |a 10.1016/j.neuroimage.2012.07.001 |g Vol. 63, p. 447 - 459 |p 447 - 459 |q 63<447 - 459 |t NeuroImage |v 63 |x 1053-8119 |y 2012 |
| 856 | 7 | _ | |u http://dx.doi.org/10.1016/j.neuroimage.2012.07.001 |
| 909 | C | O | |o oai:juser.fz-juelich.de:22784 |p VDB |
| 913 | 2 | _ | |0 G:(DE-HGF)POF3-571 |1 G:(DE-HGF)POF3-570 |2 G:(DE-HGF)POF3-500 |a DE-HGF |b Key Technologies |l Decoding the Human Brain |v Connectivity and Activity |x 0 |
| 913 | 1 | _ | |0 G:(DE-HGF)POF2-89571 |a DE-HGF |v Connectivity and Activity |x 1 |4 G:(DE-HGF)POF |1 G:(DE-HGF)POF3-890 |3 G:(DE-HGF)POF3 |2 G:(DE-HGF)POF3-800 |b Programmungebundene Forschung |l ohne Programm |
| 914 | 1 | _ | |y 2012 |
| 915 | _ | _ | |0 StatID:(DE-HGF)0010 |2 StatID |a JCR/ISI refereed |
| 915 | _ | _ | |0 StatID:(DE-HGF)0100 |2 StatID |a JCR |
| 915 | _ | _ | |0 StatID:(DE-HGF)0110 |2 StatID |a WoS |b Science Citation Index |
| 915 | _ | _ | |0 StatID:(DE-HGF)0111 |2 StatID |a WoS |b Science Citation Index Expanded |
| 915 | _ | _ | |0 StatID:(DE-HGF)0150 |2 StatID |a DBCoverage |b Web of Science Core Collection |
| 915 | _ | _ | |0 StatID:(DE-HGF)0199 |2 StatID |a DBCoverage |b Thomson Reuters Master Journal List |
| 915 | _ | _ | |0 StatID:(DE-HGF)0200 |2 StatID |a DBCoverage |b SCOPUS |
| 915 | _ | _ | |0 StatID:(DE-HGF)0300 |2 StatID |a DBCoverage |b Medline |
| 915 | _ | _ | |0 StatID:(DE-HGF)0310 |2 StatID |a DBCoverage |b NCBI Molecular Biology Database |
| 915 | _ | _ | |0 StatID:(DE-HGF)0420 |2 StatID |a Nationallizenz |
| 915 | _ | _ | |0 StatID:(DE-HGF)1030 |2 StatID |a DBCoverage |b Current Contents - Life Sciences |
| 915 | _ | _ | |0 StatID:(DE-HGF)1050 |2 StatID |a DBCoverage |b BIOSIS Previews |
| 920 | 1 | _ | |0 I:(DE-Juel1)INM-2-20090406 |g INM |k INM-2 |l Molekulare Organisation des Gehirns |x 0 |
| 970 | _ | _ | |a VDB:(DE-Juel1)139543 |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a ConvertedRecord |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a I:(DE-Juel1)INM-2-20090406 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|